Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System again shown to significantly reduce surgical site complications News provided by Share this article Share this article LONDON, Jan. 27, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN,NYSE:SNN), the global medical technology business, is pleased to announce a new publication showing that its PICO Single Use Negative Pressure Wound Therapy System (sNPWT) significantly reduced the odds of surgical site infections (SSIs) by 63% *, the odds of seroma by 77% †, and the odds of dehiscence by 30% ‡. A significant benefit of these reduced odds was an almost 2-day reduction in length of stay §, suggesting potential for substantial efficiency gains across the healthcare system